Stocks

Amgen AMGN

Health care sectorNasdaq

Close
$423.68
09/29 close
Day change
+1.3%
vs previous close
Volume
134,770
−17.7% vs 30-day average
52-week range
$271.02$446.99
1-year return
+54.6%
vs the close a year ago
Market cap
$229.1B
540,632,005 shares · reported 07/30

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Thousand Oaks, California
Fiscal year end
12/31
Next earnings
11/03, estimated

Members of Congress reported 5 trades in Amgen AMGN in the past 90 days (0 purchases, 5 sales).

Korean holdings rank
Outside the top 50
Korea Securities Depository · released 09/22
Congress trades
5
Last 90 days · 0 buys · 5 sales
Insider net buying
No record
Last 90 days · 0 buys · 0 sales
Dividendquarterly
$2.52 a share
Ex-dividend 08/21 · trailing yield 1.19% (2 dividends in 12 months over the 09/29 close)
Next earnings
11/03
Estimated from the last four quarters

Price

$423.68Day +1.3%1 year +54.6%

26-week trading

Common questions

Which members of Congress traded Amgen AMGN recently?
The latest reported trades: Rep. David Taylor, full sale on 08/26 (reported 09/05), Sen. Sheldon Whitehouse, partial sale on 08/12 (reported 09/02), Sen. Tommy Tuberville, full sale on 25/04/15 (reported 08/05) and Sen. Alan Armstrong, full sale on 03/27 (reported 07/21).